<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 269 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page268.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=269">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 269 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 269</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=269"><img src="../thumb/269.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>232 / 2020-04                                                            Anti-Microbials - 18.1.2
   colit., bld.dyscras., prothromb. time prolong., skin reacts.incl. exanthe-  Side effects: Fatal Ca-ceftriaxone precipit.in lung & kidneys of term   Dosage: Adults: 750 mg 3xdly, IM/IV.
   ma /erythema multiforme/Stev.-Johns. syndr./Lyell’s syndr.& tox.epi-  & prem.infts.when concom. Ca contain.sol/prod.admin.even if line &   Sev.infects: 1,5 g 3xdly IV, freq.may be incr.to 6 hrly if necess.
   derm.necrolys., headache, dizz., oligur., genit.tract mycos., hypersens.   times of admin.differ., GI disturbs., bld.dyscras., prolong. prothromb.  Gonorrh: 1,5 g as sngl.dose.
   reacts.incl.anaphylax., loc. reacts.at inj. site, superinfect., pancreatit.  time, agranulocytos., skin & cutan. reacts., Stev.-Johns.syndr./Ly-  Prophylax., abdom.& gynae.ops: 1,5 g IV with induct., then
   Special precautions: Do not mix./admin.with Ca contain.sols./  ell’s syndr./ tox.epiderm. necrolys., CNS effs., oligur., genit. mycos.,   2x750 mg IM 8 & 16 hrs.later.
   prod.within 48 hrs., cross. placenta barr.& excret.in breast milk, sev.  hypersens.reacts.incl.anaphylact.reacts., loc. reacts. fev., shiver.,   Card.& pulm.ops: 1,5 g with induct.then 750 mg IM 3xdly x24-48 hrs.
   ren. fail., incompat.with amsacrine/vancomycin/ fluconazole & ami-  pseudomembr. interocolit., coagulat.disords., superinfect., shadows   Infts.& childr: 30-100 mg/ kg/ day as 3-4 div.dos. Tot.dos: 60 mg/
   noglycosid., hyperbilirubinaem. neonates.  detect.by gallbladd.sonogram mistak. for gallston.usual.follow.high.  dly. usual. appropr.
   Drug interactions: Precipitat. of ceftriaxone salts with concom.  than recomm.dos., pancreatit.  Side effects: Hypersens.with ac.ren.fail., skin rash, thrombophle-
   Ca contain.sols./prod.       Warnings and special precautions: Do not add to sol./dil.con-  bit., GI disturb., candida intertrigo, eosinophill., decr.haemoglob.
   SANDOZ CEFUROXIME, Sandoz [P/S]  tain.Ca, observ.48 hr betw. admin. of any Ca contain.sols./prod.incl.  conc., super-infect.
                                parenter. nutrit. & ceftriaxone, no data avail.on potent. interact. with
                                                              Special precautions: Imp.ren.funct., monit.ren. funct., penicill.
   Cefuroxime axetil.equiv.to cefuroxime  oral Ca contain.prod./IM ceftriaxone & Ca contain.IV/oral products,   cross sens., antibiot.colit., don’t admin.concom.with other medicat.
   Indications: Pharyngit., tonsilit., otit.media, sinusit., ac.& chron.bron-  cross. placent.barr., excret. in breast milk, safety in pregn. & lactat.  Drug interactions: Poss.incr.nephrotoxic.with furosemide & ami-
   chit., ac.uncompl.cystit., Lyme dis.caus.by suscept.organ.  not est., sev.ren./hepat.dysfunct., incompat. with vancomycin, flu-  noglycosides.
   (S4) TABS, 37/20.1.1/0055, A37/20.1.1/ 0056  conazole & aminoglycosides, not recomm.in neonates esp. prems.
   703867-001: 250 mg, 10, R119,29  at risk of bilirubin encephalopathy, consid. pseudomembr.colit.in pts.  ZINFORO, Pfizer [P/S]
   703868-001: 500 mg, 10, R200,67  present.with diarrh. subseq.to treatm., superinfects.with non-suscept.   Ceftaroline
   Dosage: Admin.½.hr.aft.food.  organisms., IMI without lidocaine is painf.  Indications: Suscept.ac.bact.skin & skin struct. infects., commun.
   Adults:                      Interactions: Ca-ceftriaxone precipit.in lung & kidneys with concom.   acquir.bact.pneum.
   Sinusit., ac.& chron.bronchit: 250 mg 2xdly x7 days. (Range   Ca contain.sol/prod., poss. false-pos. Coombs/galactomsaem.tests,   (S4) POWD.FOR CONC.FOR SOL.FOR INFUS., 46/20.1.1/0628
   5-10 days)                   poss false-pos.in non-enzymat.gluc.determinat.in urine  721825-001: 600 mg/vial, 10 vials, R8 698,77
   Ac.uncomplicat.cystit: 125 mg 2xdly x7 days. (Range 5-10 days)  Dosage: Vials for sngl.use only.
   Lyme dis: Adults & childr.over 12 yrs: 500 mg 2xdly x20 days  ZEFKOL, Litha [P/S]  Pts.&gt; 18 yrs: Recomm.dos: 600 mg 12 hrly.infus. IV over 60 mins.
   Childr.                      Cefazolin sodium equiv.to cefazolin.  x5-14 days in ac.bact.skin & skin struct.infects.& x5-7 days in CABP.
   3 mnths-2 yrs: 125 mg 2xdly. Over 2 yrs: 250 mg 2xdly.   Indications: Resp.tract/GUT/skin & soft tiss./ bone & joint infects./  Contraindications: Other beta-lact.antibact. agent hypersens.
   Contraindications: Penicill.& other ß-lactam antibiot., safety in   septicaem.& endocardit. caus.by suscept.organ., peri-operat./intra-  Side effects: Common: Diarrh., N&V, abdom. pain, headache, diz-
   pregn.& lactat.not est., childr. und.3 mnths.  operat.& post-op. prophylax.in abdom.hysterect.  zin,, rash, prurit., incr. transamin., phlebit., pyrex. Uncomm: Anaem.,
   Side effects: Eosinophil., headache, GI disturbs., vag.candidias.,   (S4) POWD.FOR INJ, 37/20.1.1/0136,0137  thrombocytopen., hypersens./ anaphylax., urticar., C difficile, prolong.
   trans.incr.in hepat. enzym.lev., skin reacts.incl.erythema multiforme/  718070-001: 0,5 g, 10 vials, R100,16  prothromb.time incr.INR, incr. bld. creatin., infus.site reacts.
   Stev.John.& tox. epiderm.necrolys., hypersens.reacts.incl.skin re-  718071-001: 1 g, 10 vials, R111,41  Warnings and special precautions: Hypersens. hist.to cepha-
   acts./ bronchosp.& anaphylax., super-infect., Jarisch-Hexheimer   Dosage: Admin.deep IM/reconstit.in min.10 ml ster.H2O for inj.by   lospor./penicill.& other beta-lactam., antibact.assoc.colit.& pseu-
   follow.Lyme dis.treatm.      slow IV over 3-5 mins./ IV infus.   domembr.colit., pre-exist. seiz.disords., posit.direct antiglobulin test
   Special precautions: GI dis.hist., ren.impairm., porphyr., poss.  Adults: 250 mg-1,5 g 6-8-12 hrly. Sev.infect: 1 g-1,5 g 6 hrly.  developm., ren.impairm., do not use in pregn.as no clinic.data avail.,
   pseudomembr.colit.           Childr: 25-50 mg/kg bm/day in 3-4 div.dos. May be incr.to 100 mg/  no breastfeed.as many beta-lact. excret.in breast milk, safety & ef-
   Drug interactions: Area und.mean ser.conc. time-curve incr.by   kg bm/day in sev.infects.  fic.in paed.pts. not est.
   probenecid.                  Peri-op.prophylax: 1 g IV/IM ½-1 hr.prior to surg. For proced.2 hrs.  ZINNAT, GSK [P/S] &
   TAZIJECT, Litha [P/S]        or long.1 g IV/IM dur. proced. (modify admin.accord.to proced.durat.)   Cefuroxime as cefuroxime axetil.
                                then 1 g IV/IM 6-8 hrly. postop x24 hrs.max.
   Ceftazidime pentahydr.equiv.to ceftazidime  Contraindications: Safety in pregn./lactat.& use in prems.& infts.  Indications: Pharyngit., tonsillit., otit.media, sinusit., ac.& chron.
   Indications: Sev.infect.incl.septicaem./, bacteraem./ peritonit.&   und.1 mnth.not est., intrathec. admin.  bronchit., ac.uncompl.cystit., Lyme dis.
   in immuno-compromis. pts., RTI, ENT, UTI, skin & soft tiss., GI, bil.&   Side effects: Freq: Eosinophil., headache, abdom/ stomach cramps,   (S4) TABS, [P/S] V/20.1.1/362, 363, 364.
   abdom. infect. caus.by suscept.organisms  N&V, anorex., diarrh., oral/ vag.candidias., genit./anal prurit., genit.   781320-003: 125 mg, 10, R105,80
   (S4) INJ, A39/20.1.1/0125, 0126, 0127  monilias., vaginit. Less freq: Hypersens.reacts. incl. anaphylax., neu-  781339-006: 250 mg, 10, R162,77
   705569-001: 0,5 g, 1 vial, R76,64  tropen., leucopen., agranulocytos., thrombocytopen., dizzin., hear.loss,   781347-009: 500 mg, 10, R297,33
   705570-001: 1 g, 1 vial, R94,12  pseudomembr. colit., dyspeps., flatul., skin rash, urticar., tox.epiderm.  Dosage: Do not crush tabs. Admin. 2xdly ½.hr.aft. food x5-10 days.
   705572-001: 2 g, 1 vial, R188,28  necrolys./Stev.-John.syndr./ erythema multiforme, interstit.nephrit./  Adults: Sinusit., ac.& chron.bronchit: 250 mg.
   Dosage: Admin deep IM inj./slow IV inj.over 3-5 mins./ IV infus.over   other ren. disords., IMI pain, phlebit.at inj.site, Freq. unknown: Hy-  Ac.uncompl.cystit: 125 mg.
   approx.30 mins. Sngl.dos.over 1 g given IV.  poprothrombinaem., bleed.disords. aplast. anaem., haemorrh., pan-  Lyme dis: Adults & childr.over 12 yrs: 500 mg for 20 days.
   Adults: 1-6 g/dly.in div.dos.every 8 to 12 hrs. High. dos.in sev.in-  cytopen., confus., stupor, hepatit.& cholestat. jaund., superinfects.  (S4) SUSP, [P/S] Z/20.1.1/148. 125 mg/5 ml.
   fect.esp.immunocompromis. Up to 9 g dly. in adults with norm.  Warnings and special precautions: Penicill. cross-sens., prev.  814091-008: 50 ml, R91,67
   functs. Cystic fibros.with pseudomon.lung infect: 90-150 mg/  drug allerg., discont. ther./instit. appropr.treatm.if allerg.react.occur,   814091-016: 100 ml, R183,34
   kg bm dly.in 3 div.dos.      GI dis.hist. partic.colit., superinfect., pseudomembr. colit. somet.assoc.  Dosage: Admin. ½ hr.aft.food.
   Childr: 30-100 mg/kg dly.in 2-3 div.dos. Sev.ill: 150 mg/kg dly to max   with ther.& poss. life-threat., risk/ benef.in ren.funct.impairm., con-  Childr: usual.125 mg 2xdly.
   of 6 g dly.in 3 div.dos.     vuls.& CNS toxic. follow.high dos.esp.in sev.ren. impairm., safety in   Otit.med: Childr.und.2 yrs: 125 mg 2xdly. Over 2 yrs: 250 mg
   Neonates & infts 0-2 mnths: 25-60 mg/kg dly.in 2 div.dos.   pregn.& lactat.not est., cross.placenta, excret.in breast milk, monit.  2xdly x5-10 days. Childr.und.3 mnths: No exper.
   Elderly: Gen.not exceed.3 g dly.  prothromb. INR in case of liv./ ren.impairm./poor nutrit.state/prolong.  Side effects: Comm: Candida overgr., eosinophil., headache,
   Contraindications: Cephalospor.hypersens.  antimicrob. ther./ pts.prev.stabil.on anticoags.  dizzin., diarrh., naus., abdom.pain, incr. hepat.enzym.lev. Uncomm:
   Side effects: Freq: Immune syst.disords., hypersens. incl.skin re-  Interactions: Probenecid incr.& prolongs bld. conc., combin.K & loop   Posit.Coombs’ test, thrombocytopen., leucopen., hypersens.reacts.
                                                         +
   acts. & anaphylax.           diuret./aminoglycosid. incr. ren.funct.impairm.incid.  incl. skin rash., vomit, haemolyt.anaem., urticar., prurit., drug fev.,
   Less freq: Bld dyscras., bleed.complicat.relat.to hypothrombinaem./  ser.sickn., anaphylax., pseudomenbr. colit., jaund., hepatit., erythe-
   platelet.dysfunct., haemolyt. anaem., super-infect., GI-disturbs., pseu-  ZEFURIME, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  ma multiforme, Stev.-John. Syndr., tox.epiderm.necrolys., self-limit.
   domembr. colit., hepato-bil.disords., CNS effs.esp.at high dos., ren/  Cefuroxime as cefuroxime axetil.  Jarisch-Herxheimer react.follow. Lyme dis.treatm.
   urin.disords., inj.site pain, thrombophlebit.  Indications: Pharyngit., tonsilit., otit.media, sinusit., ac.& chron.  Warnings and special precautions: Poss. penicill./ cephalo-
   Warnings and special precautions: Penicill. sens., safety in   bronchit., ac.uncompl.cystit., Lyme dis.  spor.cross sens., phenylketonur./ diab. pts.as susp.cont. aspartame,
   pregn.& lactat.not est. known hist. of allerg., imp.ren.funct., elderly.,   (S4) TABS, 41/20.1.1/0721, 0722  poss.eff.on glycaem. contr.in pts with diab.mellit.as susp. cont.
   monit.ren./ haematolog. stat.dur.prolong.& high dos.ther., incompat.   713006-001: 250 mg, 10, R126,72  sucrose, avoid concom.furosemide, concom. aminoglycosid., poss.
   with aminoglycos.& vancomycin theref. flush giv.sets betw.admin.,   713007-001: 500 mg, 10, R231,49  pseudomembr.colit., do not admin. simultan.with other meds.,
   poss.pseudomembr. colit., may affect/interf.with Jaffe meth.of meas.   Dosage: Admin. 2xdly ½.hr.aft.food x5-10 days.  safety in pregn. & lactat.not est., lact.intol.
   creatinine/ Coombs test/urine gluc.tests  Adults:          Interactions: Poss.reduc.OC effic.
   Interactions: Enhanc.nephrotoxic.with furosemide & nephrotox.meds.,   Sinusit., ac.& chron.bronchit: 250 mg.  See also MDR page 380.
   probenecid inhibits.ren.excret., antagon. with bacteriostat.antibact.  Ac.uncomplic.cystit: 125 mg.
                                Lyme dis: Adults & childr.over 12 yrs: 500 mg for 20 days.  ZINOXIME, Actor Pharma [P/S]
   TRIAXIPHIN, Ranbaxy [P/S]    Children:                     Cefuroxime axetil.equiv.to cefuroxime.
   Ceftriaxone.                 Lyme dis: No exper.in childr.und.3 mnths. Childr: 3 mnths-2 yrs:   Indications: U&LRTI, ac.uncomplic.cystit.& Lyme dis.caus.by
   Indications: Bacter.septicem., meningit., intra-abdom., skin/skin   125 mg. Over 2 yrs: 250 mg  suscept.organ.
   struct./bone/joint/ren.& urin. tract/ RTI/ ENT infects., uncomplic.  Contraindications: Penicill.& other beta-lactam antibiot.hypersens.,   (S4) TABS, 41/20.1.10753
   gonorrh., peri-op.infect.prophylax.  safety in pregn.& lactat.not est.  715261-001: 500 mg, 10, R251,81
   (S4) INJ. A38/20.1.1/0552, 0550  Side effects: Pseudomembr.colit., eosinophil., headache, GI-dis-  Dosage: Admin.½.hr.aft.food.
   705355-001: 500 mg, 1 vial, R38,67  turbs., vag.candidias., skin reacts. incl.erythema multiforme/Stev.  Adults:
   705356-001: 1 g, 1 vial, R43,20  John.syndr./tox. epiderm. necrolys., hypersens.reacts.incl. anaphy-  Sinusit., ac.& chron.bronchit: 250 mg 2xdly x7 days. (Range
   Dosage: Do not mix with/admin.simultan.with Ca contain.sols./  lax., bronchosp., self-limit.Jarisch-Herxheimer react.follow.Lyme dis.  5-10 days)
   products even via diff.infus. lines. Admin.IM/IV. IV dos.of &gt; 50 mg/  treatm., trans. incr. in hepat.enzyme.lev.  Ac.uncomplicat.cystit: 125 mg 2xdly x7 days. (Range 5-10 days)
   kg bm.to be infus. over at least 30 mins. Durat.of ther.for min. of 48-  Special precautions: GI dis.hist.esp.ulcerat. colit./ reg.enterit.&   Lyme dis: Adults & childr.over 12 yrs: 500 mg 2xdly x20 days
   72 hrs.aft. pt.afebr./evid.bact. eradicat.  pseudomembr.colit., imp.ren. funct., safety not est.in porphyr., supra-  Childr: 3 mnths-2 yrs: 125 mg 2xdly. Over 2 yrs: 250 mg 2xdly
   Adults & childr.over 12 yrs: 1-2 g once dly.may be incr.to 4 g dly.in   infect.with prolong.use  Contraindications: Cephalospor./penicill.& other ß-lactam hyper-
   sev.cas./infects by mod.sens. organ. Neon./infts.& childr to 12 yrs:   Drug interactions: Probenec.incr.area und.mean ser.conc.time-  sens., safety in porphyr.not est., safety & effic.in pregn.& lactat.not
   Neonat. i.e. prem/term infts.(to 14 days.) 20-50 mg/kg bm. dly. Dly   curve   est., no exper. in childr.und.3 mnths.
   dose not to exceed 50 mg/kg bm. Infts. & childr.(15 days-12 yrs.): 20-  Side effects: Bld.dyscras., headache, GI disturbs., vag.candidias.,
   80 mg/kg once dly. Childr.50 kg/more: Usual adult dos.  ZINACEF, GSK [P/S]  skin reacts.incl.erythema multiforme /Stev.John.& tox.epiderm.
   Bact.meningit: Neonates /infts.& childr: Init. 100 mg/kg (not to   Cefuroxime as cefuroxime sod.  necrolys., hypersens.reacts.incl.anaphylax., supra-infect., Jarisch-
   exceed 4 g) once dly., adapt dos. accord.once organ.& sens.deter-  Indications: RTI/UTI/soft tiss./ENT/gynae. infects.& gonorrh.caus.by   Herxheimer follow.Lyme dis.treatm.
   min. Adults: 4 g once dly.   suscept.organ., prophylax.bef.surg. where incr.infect.risk.  Special precautions: GI dis.hist.esp.ulcer.colit. /region.enterit./
   Gonorrh: 125 mg IM as sngl.dose.  (S4) INJ, [P/S] L/20.1.1/96, 97, 98.  pseudomembr.colit., ren.funct. impairm., discont.treatm.immed.
   Periop.-prophylax: Sngl.dos.of 1-2 g 30-90 mins. prior to surg.  779229-003: 250 mg, 1 vial, R58,39  if pseudomembr. colit.susp., overgrowth of non-suscept.organ.
   Contraindications: Penicill.hypersens., hyperbilirubinaem.neonates   779237-006: 750 mg, 1 vial, R83,35  with prolong.use.
   esp.prems., concom.Ca contain.sol/prod. irrespect.of age,   779245-008: 1,5 g, 1 vial, R150,02  Drug interactions: Probenecid incr.AUC.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page268.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page264.html">264</a>&nbsp;&nbsp;&nbsp;<a href="page265.html">265</a>&nbsp;&nbsp;&nbsp;<a href="page266.html">266</a>&nbsp;&nbsp;&nbsp;<a href="page267.html">267</a>&nbsp;&nbsp;&nbsp;<a href="page268.html">268</a>&nbsp;&nbsp;&nbsp;<a href="page269.html">269</a>&nbsp;&nbsp;&nbsp;<a href="page270.html">270</a>&nbsp;&nbsp;&nbsp;<a href="page271.html">271</a>&nbsp;&nbsp;&nbsp;<a href="page272.html">272</a>&nbsp;&nbsp;&nbsp;<a href="page273.html">273</a>&nbsp;&nbsp;&nbsp;<a href="page274.html">274</a>
             </td>
             <td width="35%"><a href="page270.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page270.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
